Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vardenafil and CPAP for erectile dysfunction in men with obstructive sleep apnoea
ACTRN12610000144011Phase 4Completed
- Sponsor
- National Health and Medical Research Council
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of vardenafil in erectile dysfunction (ED) and obstructive sleep apnea hypopnea syndrome (OSAHS) (4 arms), sponsored by National Health and Medical Research Council. Primary endpoint: Erectile function via the International Index of Erectile Function. Started May 2010; status: completed.
02
Drugs
vardenafil
03
Conditions
erectile dysfunction (ED)obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ACTRN12610000144011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000144011.